News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spectral Molecular Imaging, Inc. Reaffirms Commitment to Early Detection of Melanoma by Hyperspectral Imaging


11/19/2010 11:22:30 AM

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Cascade Technologies, Corp. (OTCBB: CSDT) announced today that, in response to significant recent attention to the Food and Drug Administration (FDA) panel evaluation of Mela Sciences’ (Nasdaq: MELA) MelaFindTM device, the company has received a number of inquiries about its similar instrument. "We believe," said Dr. Daniel Farkas, Chairman and CEO, "that it is useful to reaffirm our position on the non-invasive detection of melanoma by our SkinSpectTM device under development."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES